Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019359950> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2019359950 endingPage "375" @default.
- W2019359950 startingPage "375" @default.
- W2019359950 abstract "The bioavailability of potassium and magnesium, and the citraturic response were determined for the new compound, potassium-magnesium citrate, in 14 normal volunteers. Results were compared to those of potassium citrate and magnesium citrate. Each subject participated in 4 phases of study: potassium-magnesium citrate, potassium citrate, magnesium citrate and potassium chloride. After stabilization on a metabolic diet, each subject ingested a single load of a test medication followed by timed urine collections for the next 24 hours. Test loads included potassium-magnesium citrate (49 mEq. potassium, 24.5 mEq. magnesium and 73.5 mEq. citrate), potassium citrate (50 mEq.), potassium chloride (50 mEq.) and magnesium citrate (25 mEq.). Urinary potassium, magnesium and citrate were measured for each collection period.Potassium-magnesium citrate provided an equivalent potassium bioavailability as potassium citrate and potassium chloride, and a comparable magnesium bioavailability as magnesium citrate. However, it gave the highest citraturic response, since the cumulative increment in urinary citrate post-load was 129 mg. daily for potassium-magnesium citrate, 105 mg. daily for potassium citrate and 35 mg. daily for magnesium citrate. Thus, potassium-magnesium citrate gave an optimum citraturic response in addition to providing absorbable potassium and magnesium." @default.
- W2019359950 created "2016-06-24" @default.
- W2019359950 creator A5008261341 @default.
- W2019359950 creator A5016202103 @default.
- W2019359950 creator A5017042566 @default.
- W2019359950 creator A5025487051 @default.
- W2019359950 creator A5027674342 @default.
- W2019359950 creator A5041074432 @default.
- W2019359950 creator A5053881629 @default.
- W2019359950 creator A5062301570 @default.
- W2019359950 creator A5079856009 @default.
- W2019359950 date "2009-09-01" @default.
- W2019359950 modified "2023-09-27" @default.
- W2019359950 title "6546 Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer" @default.
- W2019359950 doi "https://doi.org/10.1016/s1359-6349(09)71268-6" @default.
- W2019359950 hasPublicationYear "2009" @default.
- W2019359950 type Work @default.
- W2019359950 sameAs 2019359950 @default.
- W2019359950 citedByCount "0" @default.
- W2019359950 crossrefType "journal-article" @default.
- W2019359950 hasAuthorship W2019359950A5008261341 @default.
- W2019359950 hasAuthorship W2019359950A5016202103 @default.
- W2019359950 hasAuthorship W2019359950A5017042566 @default.
- W2019359950 hasAuthorship W2019359950A5025487051 @default.
- W2019359950 hasAuthorship W2019359950A5027674342 @default.
- W2019359950 hasAuthorship W2019359950A5041074432 @default.
- W2019359950 hasAuthorship W2019359950A5053881629 @default.
- W2019359950 hasAuthorship W2019359950A5062301570 @default.
- W2019359950 hasAuthorship W2019359950A5079856009 @default.
- W2019359950 hasConcept C178790620 @default.
- W2019359950 hasConcept C179104552 @default.
- W2019359950 hasConcept C181389837 @default.
- W2019359950 hasConcept C185592680 @default.
- W2019359950 hasConcept C2779032678 @default.
- W2019359950 hasConcept C517785266 @default.
- W2019359950 hasConcept C543218039 @default.
- W2019359950 hasConcept C55493867 @default.
- W2019359950 hasConcept C71924100 @default.
- W2019359950 hasConcept C98274493 @default.
- W2019359950 hasConceptScore W2019359950C178790620 @default.
- W2019359950 hasConceptScore W2019359950C179104552 @default.
- W2019359950 hasConceptScore W2019359950C181389837 @default.
- W2019359950 hasConceptScore W2019359950C185592680 @default.
- W2019359950 hasConceptScore W2019359950C2779032678 @default.
- W2019359950 hasConceptScore W2019359950C517785266 @default.
- W2019359950 hasConceptScore W2019359950C543218039 @default.
- W2019359950 hasConceptScore W2019359950C55493867 @default.
- W2019359950 hasConceptScore W2019359950C71924100 @default.
- W2019359950 hasConceptScore W2019359950C98274493 @default.
- W2019359950 hasIssue "2" @default.
- W2019359950 hasLocation W20193599501 @default.
- W2019359950 hasOpenAccess W2019359950 @default.
- W2019359950 hasPrimaryLocation W20193599501 @default.
- W2019359950 hasRelatedWork W1981285340 @default.
- W2019359950 hasRelatedWork W2009915262 @default.
- W2019359950 hasRelatedWork W2045804700 @default.
- W2019359950 hasRelatedWork W2078767999 @default.
- W2019359950 hasRelatedWork W2086632508 @default.
- W2019359950 hasRelatedWork W2324505270 @default.
- W2019359950 hasRelatedWork W2343880745 @default.
- W2019359950 hasRelatedWork W2378784350 @default.
- W2019359950 hasRelatedWork W2409741267 @default.
- W2019359950 hasRelatedWork W2559794569 @default.
- W2019359950 hasVolume "7" @default.
- W2019359950 isParatext "false" @default.
- W2019359950 isRetracted "false" @default.
- W2019359950 magId "2019359950" @default.
- W2019359950 workType "article" @default.